Endometriosis, a disease of the macrophage by Annalisa Capobianco
“ﬁmmu-04-00009” — 2013/1/25 — 13:16 — page 1 — #1
REVIEW ARTICLE
published: 28 January 2013
doi: 10.3389/ﬁmmu.2013.00009
Endometriosis, a disease of the macrophage
Annalisa Capobianco and Patrizia Rovere-Querini*
Division of Regenerative Medicine, Stem Cells and GeneTherapy, San Raffaele Scientiﬁc Institute, Milan, Italy
Edited by:
Anna Rubartelli, National Cancer
Research Institute, Italy
Reviewed by:
Paola Allavena, Clinical Institute
Humanitas, Italy
Junji Yodoi, Kyoto University, Japan





Unit, San Raffaele Scientiﬁc Institute,
DIBIT 3A1, Via Olgettina 58, 20132
Milano, Italy.
e-mail: rovere.patrizia@hsr.it
Endometriosis, a common cause of pelvic pain and female infertility, depends on the
growth of vascularized endometrial tissue at ectopic sites. Endometrial fragments reach the
peritoneal cavity during the fertile years: local cues decidewhether they yield endometriotic
lesions. Macrophages are recruited at sites of hypoxia and tissue stress, where they clear
cell debris and heme-iron and generate pro-life and pro-angiogenesis signals. Macrophages
are abundant in endometriotic lesions, where are recruited and undergo alternative
activation. In rodents macrophages are required for lesions to establish and to grow;
bone marrow-derived Tie-2 expressing macrophages speciﬁcally contribute to lesions
neovasculature, possibly because they concur to the recruitment of circulating endothelial
progenitors, and sustain their survival and the integrity of the vessel wall. Macrophages
sense cues (hypoxia, cell death, iron overload) in the lesions and react delivering signals to
restore the local homeostasis: their action represents a necessary, non-redundant step
in the natural history of the disease. Endometriosis may be due to a misperception
of macrophages about ectopic endometrial tissue. They perceive it as a wound, they
activate programs leading to ectopic cell survival and tissue vascularization. Clearing this
misperception is a critical area for the development of novel medical treatments of
endometriosis, an urgent and unmet medical need.
Keywords: endometriosis, alternatively activated macrophages, angiogenesis,Tie-2 expressing macrophages, iron,
phagocytosis, hypoxia
INTRODUCTION
Endometriosis is a common condition, affecting a rather large
fraction of menstruating women, characterized by the hormone-
dependent persistence and growth of vascularized endometrial
tissue at ectopic sites, typically the pelvis, with pain and reduced
fertility (Lebovic et al., 2001; Giudice and Kao, 2004; Berkley et al.,
2005; Bulun, 2009; Luisi et al., 2009; Giudice, 2010; Simoens
et al., 2012). Lesions are thought to originate from endome-
trial fragments shed during menstruations, which reach via
the Fallopian tubes the peritoneal cavity. The event, which is
likely to physiologically occur in most women, endometriotic
and non-endometriotic, is referred to as “retrograde menstrua-
tion” (Sampson, 1927). Supporting evidence is mostly indirect.
Endometriosis for example only takes place in species that men-
struate, such as primates: this suggests that menstruation is
required for the disease (D’Hooghe and Debrock, 2002). Shed
endometrium is thought to initially adhere to endoabdominal
structures, in particular the peritoneal wall and ovaries. Adhesion
probably occurs quite commonly in healthy, non-endometriotic
women. In in vitro models, adhesion requires a relatively
short time and is apparently actively supported by mesothelial
cells (Lucidi et al., 2005; Nair et al., 2008), with an apparently
healthy peritoneum that thus play an important facilitatory role
in the further development of endometriotic lesions (Fassbender
et al., 2011).
A further necessary step for lesions establishment is the capac-
ity of ectopic endometrial cells to invade the underlying basement
membrane. The molecular bases of this phenomenon are par-
tially elucidated. Endometrial tissue has invades even intact serosal
membranes, indicating that a previously disrupted peritoneum is
not a requirement (Nair et al., 2008).
Invasion in a prerequisite for the organization of the ectopic
endometrial cells in tridimensional cysts but is not sufﬁcient: novel
vessels are also necessary. Novel vessels originate through sprout-
ing from the adjacent vasculature or incorporation of circulating
precursor endothelial cells at sites of vascularization (Becker et al.,
2011; Laschke et al., 2011a,b). They ensure the transport of oxygen
and nutrients, the excretion of catabolites and the maintenance of
ﬂuid balance.
All together the persistence of ectopic endometriotic tissue is
associated to uncontrolled growth, invasion of adjacent tissues,
defective apoptosis, neoangiogenesis, and sustained local inﬂam-
matory responses. These features are not tissue-autonomous, but
depend on the peculiar features of the innate immune response
to the auto-transplantation of a hormone-regulated tissue at
novel sites. Of importance, several differences exist between the
eutopic endometrium of women with and without endometrio-
sis including invasive properties and resistance to apoptosis, as
well as between ectopic and autologous eutopic endometrium of
endometriotic patients (Novembri et al., 2011). This suggests that
the inﬂammatory peritoneal environment inﬂuences the behavior
of endometrial ectopic cells.
Macrophages in particular are master regulators of the innate
response to injured, infected, and neoplastic tissues. As such they
are in charge of selecting the appropriate response to restore
homeostasis: they include on one hand the identiﬁcation and
destruction of pathogens, infected or transformed cells; on the
other hand the activation, proliferation, and differentiation of
www.frontiersin.org January 2013 | Volume 4 | Article 9 | 1
“ﬁmmu-04-00009” — 2013/1/25 — 13:16 — page 2 — #2
Capobianco and Rovere-Querini Macrophages guide endometriosis
precursor/stem cell and the generation of neovessel. The percep-
tion of the role of macrophages in endometriosis has grown in the
last years: in this review we will discuss the most recent data in the
literature that name macrophages as defendants, with the charge
of contributing to cause human endometriosis.
METHODS
Literature searches were performed in PubMed, Scopus, and
ISI Web of Knowledge databases for publications focusing on
the state and functions of macrophages in human and murine
endometriosis. The searches included the key words “endometrio-
sis,” “ectopic endometrial lesions,” and “endometrium” were
matched with the key words “macrophages,” “Tie-2 expressing
macrophages,” “angiogenesis,” “hypoxia,” “innate immunity,” and
“ovarian cancer.” The bibliographic research encompasses studies
on rodents, non-human primates and humans. No limits were set
for publication dates.
ENDOMETRIUM AND ANGIOGENESIS
Organ vasculature comprises an integrated system of arteries,
arterioles, capillaries, venules, and veins that ensures blood cir-
culation and the transport of oxygen and other gases to target
tissues. Blood vessels that form during growth and development
generally arise by the sprouting from pre-existing vessels, via a
process referred to as angiogenesis (Potente et al., 2011). Angio-
genesis seldom occurs in the adult organism in normal tissues
under physiologic conditions.
Endometrium represents an exception: the tightly regulated
variation of ovarian steroids estrogen and progesterone concen-
trations cyclically triggers the remodeling of the organ vasculature,
with angiogenesis and lymphangiogenesis (Girling and Rogers,
2009). Estrogens during the proliferative stage of the menstrual
cycle cause the rapid growth of the vasculature. Progesterone
during the secretory phase controls the maturation of the capil-
lary sub-epithelial plexus and the development/coiling of spiral
arterioles. Finally, the swift hormone withdrawal triggers the
endometrial repair in the perimenstrual period.
The molecular mechanisms involved in hormone-regulated
remodeling of eutopic endometrial vessels are being actively
investigated. The vascular endothelial growth factor (VEGF)
family and associated receptors and the angiopoietin–tyrosine
kinase with Ig and epidermal growth factor homology domain
(angiopoietin/Tie-2) system play an important role, since they
connect hormonal levels to vessel remodeling (Girling and Rogers,
2009; Mints et al., 2010; Elsheikh et al., 2011; Lash et al., 2012).
Peritoneal macrophages are a well-characterized source of
VEGF and ovarian steroids regulate the production of the growth
factor (McLaren et al., 1996). Estrogens act on variousmacrophage
signaling pathways, inﬂuencing in particular those related to
the ability to sustain the recruitment of inﬂammatory cells and
the remodeling of inﬂamed tissues, such as mitogen-activated
protein kinase (MAPK), phosphatidylinositide-3-kinase/protein
kinase B (PI3K/AKT), and nuclear factor-kappa B (NF-κB): as
a consequence, a deregulated response to steroids might inﬂu-
ence the survival of ectopic endometrial cells and promote
the vascularization of the lesions (Cakmak et al., 2009; Pellegrini
et al., 2012).
Premenstrual progesterone withdrawal possibly represents the
crucial event: during the late secretory phase the demise of the
corpus luteum results in the abrupt fall of bioactive progesterone.
This triggers an acute inﬂammatory response with destruction of
the upper “functional” layers of the human endometrium (for
a thorough and well-written review, see Maybin et al., 2011a):
endometrial prostaglandin (PG), PGE2 and PGF2α, are synthe-
sized that act as potent vasoconstrictor on the spiral arterioles. PG
production, spiral arteriole vasoconstriction, and local hypoxia in
turn regulate the production of chemokines, such as IL-8 (CXCL8)
and CXC chemokine ligand 12 (CXCL12) stromal cell derived
factor (SDF-1).
Inﬂammation and chemokine production results in the attrac-
tion of neutrophils, that actively contribute to the destruction
of the functional layer of the endometrium (Kaitu’u-Lino et al.,
2007): typically tissue breakdown is associated with loss of
integrity of endometrial vessel and blood cells extravasation;
endometrial fragments and blood are then ﬂushed from the uterus
to the vagina with overt menstruation.
The inﬂammatory response has a double-edged action: besides
triggering the regulated destruction of the tissue, it initiates and
guides the endometrial repair.
Progesterone withdrawal indeed causes a transient constriction
of spiral arteries in the top layers of the endometrium, which is
supposed to cause hypoxia (Fan et al., 2008). Hypoxia is the stim-
ulus that triggers vessel remodeling in injured and regenerating
tissues as well as in tumors. It elicits an adaptive response, which
is largely mediated by the hypoxia-inducible transcription factor-
1alpha (HIF1α): under hypoxic conditions HIF1α translocates to
the nucleus where it enhances and accelerates the transcription of
genes with appropriate response elements, including angiopoietin
2 (Ang-2) CXCL12 and VEGF (Wu et al., 2007, 2011; Liu et al.,
2011a; Maybin et al., 2011b,c; Wong et al., 2011; Henriet et al.,
2012; Sarkar et al., 2012). Other signals induced by hypoxia and
PG in epithelial cells and macrophages, such as connective tissue
growth factor, have been convincingly suggested to play a role in
endometrial repair (Maybin et al., 2012).
Events downstreamHIF1α nuclear translocation are not appar-
ently relevant for tissue destruction (Maybin et al., 2011a): in
contrast they are required for attraction of macrophages and
for their regenerative action in the hypoxic tissue (Du et al.,
2008; Wong et al., 2011; Sarkar et al., 2012). For example abla-
tion of HIF1α in tumor models is associated with decreased
CXCL12/SDF1α levels and a less effective recruitment of bone
marrow-derived macrophages in the tumors (Du et al., 2008).
Of critical importance for the environmental changes asso-
ciated to endometriosis (see below), the vasculature of ectopic
lesions remains dependent on the systemic concentration of hor-
mones. As such, these structures undergo a cyclic remodeling,
with synchronized tissue destruction and bleeding. This has been
well-established since the pioneering work of Markee (1978), who
has described that endometrial fragments transplanted in the eye
anterior chamber of rhesus monkeys implant connect to the iris
vasculature and grow. However, the tissue abruptly regresses after
hormone withdrawal: cyclic destruction of the ectopic tissue is
associated to coiling of spiral arterioles, vasoconstriction episodes,
and bleeding.
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The insight on the physiological control of eutopic endo-
metrium is likely to be crucial to understand why endometriosis
occurs. During menstruation red blood cells, hemoglobin, and
leucocytes accumulate in the peritoneal ﬂuid of most healthy
women (Bokor et al., 2009): this indicates that retrograde men-
struation is a fairly common event. Interestingly, retrograde
menstruation appears not to be per se more frequent or abundant
in endometriotic women (Bokor et al., 2009): therefore, the pres-
ence of endometrial tissue in the peritoneal cavity is not sufﬁcient
to cause endometriosis (Bulun,2009). The role of the genetic back-
ground and/or of environmental factors deserves better attention
and will be a hot topic for researchers in the next years.
MACROPHAGES ARE VERSATILE CELLS
Macrophages have been originally identiﬁed as an integral com-
ponent of the mononuclear phagocyte system (MPS). They
derive from bone marrow progenitors that enter the blood-
stream as monocytes. Within a relatively short time they reach
peripheral tissues where they yield resident macrophages or
antigen-presenting cells, including dendritic cells (DCs): the MPS
contributes both to pathogen elimination and to housekeeping
functions (van Furth and Cohn, 1968; Murray and Wynn, 2011).
Macrophages are professional phagocytes, since they are endowed
with the molecular machinery necessary to internalize and dis-
pose of extracellular particulate substrates, including microbes
or endogenous constituents, such as apoptotic cells or senescent
erythrocytes.
Dedicated pattern-recognition receptors (PRRs) are non-
clonally expressed by innate immune cells and by macrophages
in particular (Palm and Medzhitov, 2009). PRRs have been ini-
tially thought to have undergone evolutionary selection because
of their ability to selectively identify molecular structures referred
to as pathogen-associated molecular patterns (PAMPs) expressed
by large classes of microbes (Janeway, 1992). After PAMP recog-
nition, activation of PRRs recruits tightly coordinated events,
including: (i) the production of various cytokines that attract and
activate leukocytes (Nathan, 2002), arming them for neutraliza-
tion/elimination of invading pathogen; (ii) the activation of an
acute phase response, with the production of conserved soluble
PRRs, such as pentraxins (Manfredi et al., 2008). Acute phase pro-
teins in turn tune leukocyte activation and quench their ability to
collaterally damage the tissue.
Besides microbial PAMPs, endogenous moieties trigger the
PRR activation: damage-associated molecular pattern (DAMP)
comprise an array of heterogeneous molecules that are released
during cell and tissue necrosis and that via PRR activation elicit
inﬂammation and prompt tissue regeneration even in the con-
text of sterile injuries (Maroso et al., 1996; Bianchi, 2007; Lotze
et al., 2007; Rubartelli and Lotze, 2007; Urbonaviciute et al., 2008;
Bianchi and Manfredi, 2009; Manfredi and Rovere-Querini, 2010;
Zhang et al., 2010a; Castiglioni et al., 2011; Liu et al., 2011b).
Pattern-recognition receptors represent a crucial asset for the
phagocytic ability of macrophages: they on one hand interact with
the phagocytic substrate and on the other hand activate speciﬁc
signaling cascades within the phagocyte. The characteristics of the
signaling events are crucial to determine which array of soluble
signals is produced.
An example is given by the signal transduction associated
with the best-characterized family of PRRs, the Toll-like recep-
tors (TLR): TLR 3, 7, and 9 are preferentially expressed in
endosomes, where they have access to viral constituents. As a
consequence, they activate PI3K/mTOR/S6K with downstream
production of antiviral and pro-inﬂammatory cytokines, such as
type 1 interferons: the resulting response eventually leads to virus
elimination.
TLR4, which is expressed at the plasma membrane, together
with other extracellular moieties such as MD-2 and CD14, recog-
nizes gram-negative bacteria lipopolysaccharide. Its recruitment
results, via MyD88-dependent and -independent pathways, in
NF-kB nuclear translocation and in the recruitment of the kinase
pathways with an eventual production of inﬂammatory cytokines
such as tumor necrosis factor (TNF)-α and interleukin (IL)-6: the
response is crucial for the control of the infection (Kawai and
Akira, 2011). The activation of other PRRs, such as those that
recognize dying cells phagocytic tags, prompts the production of
immunosuppressive cytokines, such as IL-10 and transforming
growth factor β (TGF-β) and of factors implicated in the tissue
regeneration and repair (Huynh et al., 2002; Ravichandran, 2011).
Thus, PRRs decipher the code associated to an infected or
injured tissue, and thus enable macrophages to activate the
innate/acquired immune response that is more functional for
restoring homeostasis (Brancato and Albina, 2011; Murray and
Wynn, 2011). Conversely, macrophages extensively reprogram
their functional properties in response toPAMPs andDAMPs (Nau
et al., 2002; Martinon et al., 2010; London et al., 2011).
During sterile inﬂammation, which is by deﬁnition driven by
DAMPs exclusively, macrophages play crucial and non-redundant
actions inmatrix remodeling and angiogenesis, which are required
for effective tissue healing (Vezzoli et al., 2010; Bosurgi et al., 2011;
Castiglioni et al., 2011; Rock et al., 2011; Vezzoli et al., 2011).
Macrophages have a rather heterogeneous array of charac-
teristics, which possibly reﬂects the diverse functions they exert
within the microenvironment: they become effector cells that kill
invading pathogens, such as mycobacteria or Leishmania major
and dramatically modify the environment via the production of
cytokines and reactive oxygen (ROS) and nitric oxide (NO) species
(Darrah et al., 2007; Mylonas et al., 2009). Such macrophages are
referred to as classically activated/inﬂammatory macrophages, or
M1 cells (Figure 1).
Macrophages also undergo a distinct activation program
(“alternative activation”): as a consequence they tune inﬂam-
matory responses and adaptive immunity, scavenge debris and
promote angiogenesis, tissue remodeling, and repair (Mantovani
et al., 2004; Gordon and Taylor, 2005). Macrophages within regen-
erating tissues are often alternatively activated, also termed “M2
cells” (Figure 1; Daley et al., 2010; Gordon and Martinez, 2010;
O’Brien et al., 2010; Schwartz, 2010; Brancato and Albina, 2011;
Cairo et al., 2011; Corna et al., 2010; David and Kroner, 2011;
Harel-Adar et al., 2011; Jaeschke, 2011; London et al., 2011; Wang
and Harris, 2011) In contrast, uncontrolled classical activation
in general results in defective healing and persistent inﬂamma-
tion (Gordon, 2003; Sindrilaru et al., 2011) Recent elegant studies
suggest that neural stem cells in a model of murine sterile spinal
cord injury possibly direct physically interact with endogenous
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FIGURE 1 | Macrophages come in different flavors. Microbial
components such as lipopolysaccharide (LPS) and/or cytokines such
as IFN-γ or GM-CSF elicit conventionally activated macrophages.
These cells secrete inﬂammatory cytokines and generate molecules
involved in the anti-bacterial response, such as reactive oxygen species
(ROS). Treatment with different cytokines like IL-4 and/or IL-13, IL-10 and/or
M-CSF supports the activation of alternative activated macrophages. Local
hypoxia, possibly in conjunction with chemotactic signals such as CXCL12
and/or DAMPs, such as HMGB1, recruit from the blood precursors that yield
Tie-expressing macrophages in the inﬂamed tissues. The expression of
speciﬁc arrays of membrane receptors and the generation of soluble and
gaseous messengers reﬂect the macrophage activation programs. LPS,
lipopolysaccharide; IFN-γ, interferon-γ; GM-CSF, granulocyte
macrophage-colony stimulating factor; M-CSF, macrophage-colony
stimulating factor; MHCII, major histocompatibility complex class II; CD163,
haptoglobin–hemoglobin complex receptor; CD206, mannose receptor; TGF-β,
transforming growth factor β; PGE2, prostaglandin E2; ROS, reactive oxygen
species.
macrophages, an event that modulates expression levels of inﬂam-
matory cell transcripts in vivo, with a shift from “classically
activated” (M1-like) macrophages to cells that facilitating the
healing or regeneration of the lesion (Cusimano et al., 2012). This
is not an exception due to the environment of the spinal cord: a
similar shift occurs in injured skeletal muscles, apparently facili-
tated by the signals derived from the apoptotic substrates (Arnold
et al., 2007).
Recombinant cytokines can be used to activate macrophage
precursors. Alternatively activated macrophages can be propa-
gated in vitro by exposing monocytes or bone marrow precursors
to low concentrations of macrophage-colony stimulating factor
(M-CSF) in the presence of IL-4, IL-13, or IL-10 (Gordon, 2003;
Mantovani et al., 2004). Exposure to microbial components in the
presence of γIFN or to granulocyte macrophage-colony stimu-
lating factor (GM-CSF) elicits classically activated, inﬂammatory
macrophages.
Speciﬁc subpopulations of macrophages are preferentially
involved in guiding angiogenesis (Qian and Pollard, 2010; De
Palma and Naldini, 2011). Macrophages that express the Tie-2
receptor (TEMor Tie-2-expressingmonocytes/macrophages) sus-
tain neoangiogenesis in a variety of experimental tumor models
(Figure 1). Circulating monocytes in normal conditions express
limited amounts of Tie-2: however, they substantially up-regulate
it after homing to hypoxic tissue, where they yield a subset of
perivascular macrophages (Du et al., 2008; De Palma and Naldini,
2009; Squadrito and De Palma, 2011). Angiopoietins, cytokines
that regulate the quiescent and the angiogenic microvasculature,
are known ligands of Tie-2: in vivo studies inwhichTEMshadbeen
speciﬁcally depleted demonstrate that they are required to sup-
port angiogenesis and accelerate tumor growth (De Palma et al.,
2003, 2005), indicating that TEMs interaction with the angiogenic
vasculature plays a non-redundant role.
The model that apparently better ﬁt with the data obtained
in these diverse systems regards macrophages as guardians of
the tissue integrity, that are in charge of: (i) perceiving clear
and actual injury in the tissue; (ii) clearing dying cells and tis-
sue debris; (iii) regulating neovessel generation and extracellular
matrix remodeling; (iv) sustaining stem and progenitor cells
migration, proliferation, survival, and differentiation (Lolmede
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et al., 2009; Stappenbeck and Miyoshi, 2009; Sun et al., 2009; Vez-
zoli et al., 2010; Zhang et al., 2010b; Ehninger and Trumpp, 2011;
Hara et al., 2011; London et al., 2011).
Macrophage activation is effective at enforcing regenerative and
vascular responses that conduce to tissue repair with restitutio
ad integrum when original injuries are intense and short lasting.
In contrast, it is likely to be detrimental when the cause(s) of
homeostasis disruption cannot be eliminated. We speculate that
this applies to human endometriosis.
ENDOMETRIOSIS, HYPOXIA, AND MACROPHAGES
Angiogenesis is a prerequisite for endometriotic lesions to estab-
lish and to grow in vivo. Endometriotic lesion neovascularization
involves both conventional sprouting angiogenesis and actual
vasculogenesis (Laschke et al., 2011a): the process shares sev-
eral features with the vessel remodeling process that take play
in injured tissues and is required for wound healing (Potente
et al., 2011). It is physiologically dependent onmacrophage activa-
tion, since the depletion of macrophages in experimental models
of wound healing jeopardizes VEGF generation and disturbs
neovascularization (van Amerongen et al., 2007; Martinez et al.,
2008). Reduced/delayed differentiation of myoﬁbroblasts, re-
epithelialization, collagen deposition, and cell proliferation also
ensue macrophage depletion and neovessel disruption (Mirza
et al., 2009).
A large bodyof evidence indicates thatmacrophages are respon-
sible for the angiogenic switch, i.e., the increase in the density of
vessels that often characterizes the benign-to-malignant transi-
tion in cancer, being involved both in the initial establishment of
the vasculature and in the subsequent remodeling of the vessels
(Pollard, 2008). Their action is mediated via several pathways,
that lead to: (i) the production of matrix metalloproteinases
(MMPs) that are required for the release of VEGF bound to the
extracellular matrix at hypoxic sites, thus increasing the avail-
ability of the bioactive growth factor; and (ii) the expression of
VEGF family members, which in turn behave as attractors of
myeloid cells, including macrophages. Of interest, an associa-
tion between endometriosis and VGEF-A gene polymorphisms
has been reported, even if caution should be used because of the
effect of possible confounding factors.
In experimental models of endometriosis, early phases of
lesion establishment are characterized by a transient hypoxia,
which results in the up-regulation of HIF1α, with downstream
expression of VEGF (Wu et al., 2007, 2011; Becker et al., 2008;
Lin et al., 2012). Limited ischemia of the endometrium in the
early and middle secretory phase occurs: the event is appar-
ently associated with the up-regulated expression of VEGF in
the late secretory phase of the menstrual cycle in endometriotic
women (Donnez et al., 1998). Interestingly, endometrial fragments
from women in which a transient ischemia had been induced by
repeated clamping/declamping of the uterine artery transplanted
onto the chick embryo chorioallantoic membrane demonstrated
higher VEGF expression and better survival: this mechanism
could facilitate implantation/establishment of endometrium at
ectopic sites (Ren et al., 2011). Moreover, response to ischemia
is likely to play a role in established lesions of endometriotic
patients: the relative expression of HIF1α and VEGF differ at
various sites within endometriotic lesions, possibly accounting for
some of their heterogeneous histological characteristics (Goteri
et al., 2004, 2010).
It is important to underline that the vascular response to
ischemia depends on the recruitment of activated macrophages
at lesions sites (e.g., see Machado et al., 2010). Macrophages are
indeed necessary to license lesions for growth and spreading (Bacci
et al., 2009; Haber et al., 2009; Capobianco et al., 2011 and see
below).
MACROPHAGES AS A KEY TO THE SUSCEPTIBILITY TO
ENDOMETRIOSIS
The data discussed above indicate that endometriosis depends
on the ability of endometrial tissue at ectopic sites to attract
macrophages and to be as a consequence licensed for sur-
vival, angiogenesis, growth, and spreading (Figures 2 and 3).
Macrophages physiologically convey these licensing signals in the
eutopic endometrium, which undergoes physiological destruction
as a consequence of progesterone withdrawal.
Inﬁltrating macrophages are a consistent feature of endometri-
otic lesions. Independent lines of evidence indicate that they
undergo activation as a consequence of signals generated within
ectopic lesion (Lebovic et al., 2001; Zhang et al., 2006; Herrmann
Lavoie et al., 2007; Lawson et al., 2007; Minici et al., 2007; Gal-
leri et al., 2008; Lousse et al., 2008) or possibly of the lack of
hormone-regulated anti-inﬂammatory signals in the ectopic but
none in the eutopic endometrium (Novembri et al., 2011). How-
ever, it is unclear whether these changes in eutopic endometrium
are primary defects or consequences of the development of
endometriosis (Novembri et al., 2011). Ectopic endometriotic
lesions are histologically similar to their putative eutopic precur-
sors. However, several genes are differentially expressed in ectopic
and eutopic of endometriotic and non-endometriotic patients
and signiﬁcant biochemical differences exist (Meola et al., 2010).
These differences might stem from epigenetic modiﬁcations that
occur in the eutopic endometrium of patients with endometrio-
sis. Differential methylation and expression of genes involved
in the regulation of implantation, such as HOXA10 and PR-
B, have been for example reported in the eutopic endometrium
of patients with endometriosis compared with controls (Stilley
et al., 2012).
In endometriotic lesions the macrophage NF-kB-dependent
pathway is engaged (Lousse et al., 2008) with transactivation of
responsive gene elements that control angiogenesis and tissue
remodeling (Hagemann et al., 2008; Timmer and Nizet, 2008).
NF-kB inhibition decreases the in vivo growth of experimental
lesions, indicating that its activation plays a particularly relevant
role (Lousse et al., 2008, 2009).
The stimuli involved in the activation of macrophages are so far
unclear. It is extremely unlikely that microbial structures (PAMPs)
are involved. As such, the signals involved in the macrophages
activation must be released in sterile conditions, like it happens
for multiorgan trauma, which causes the systemic inﬂamma-
tory response syndrome or at speciﬁc sites, as a consequence of
ischemia/reperfusion or of immune mediated events, like in the
case of allograft rejection. The endogenous sterile triggers that
are responsible for sterile inﬂammation in these conditions are
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FIGURE 2 | Macrophages in experimental and human endometriosis.
Endometrial fragments (maximal diameter <1 mm) derived from estradiol
benzoate-treated mice (A) injected intra-peritoneally yield endometriotic
lesions (B) that can be excised and processed for disease assessment (C) or
immunohistochemical evaluation (D–G). CD68+ macrophages are abundant
in human and experimental lesions (D,E). Most macrophages within
human lesions express markers of alternative activation, such as the
hemoglobin/haptoglobin CD163 scavenger receptor (F). CD163+ (green)
vWF- (blue) pro-angiogenic Tie2-expressing macrophages surround the
neoformed vessels (G).
apparently equally effective asmicrobial PAMPs and rely on similar
molecular pathways; NF-kB nuclear translocation and activation
is a clear example (Palumbo et al., 2007).
Once ectopic lesions are established, tissue remnants that are
generated as a consequence of cyclic response to progesterone
withdrawal accumulate in the peritoneal cavity since they can-
not be ﬂushed out with the menstrual blood. Cell remnants have
a potentially noxious action on living tissues: as such, they require
to be disposed by active phagocytosis. This is in general a relatively
silent event, with macrophages recognizing and phagocytosing
scattered cells that die in themidst of living tissues because of their
physiological tissue turnover, releasing in the meantime immuno-
suppressive and anti-inﬂammatory signals. However, the challenge
with a relatively ample load of cells dying in a synchronized
fashion may exert a paradoxically opposite effect, representing
a further threat to tissue integrity and immune tolerance (Rovere
et al., 1998, 2000; Manfredi et al., 2002; Capobianco et al., 2011).
Speciﬁcally the release of intracellular moieties endowed with
inﬂammatory and adjuvant properties results in the activation
of macrophages, which in turn release cytokines and chemokines,
thus enforcing a positive feed-back forward loop (Zhang et al.,
2010a; Castiglioni et al., 2011). The persistence of cells dying as
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FIGURE 3 | Macrophages drive endometriosis. Endometrial cells reach
the peritoneal cavity as a consequence of retrograde menstruation. The
recruitment of macrophages at the site of endometrial cell engraftment is a
limiting step for the lesion to organize and to growth. Local hypoxia and the
production of chemokines play a major role in the recruitment of
macrophages. Once endometriosis is established, the cyclic death of
endometrial cells as a consequence of progesterone withdrawal leads to the
release of cell debris, erythrocytes, and heme-bound iron in the peritoneal
cavity. Recruited macrophages perceive ongoing cell death and
tissue damage: in endometriotic patients they activate a
reparative/regenerative/angiogenic program that is required for lesion
maintenance, growth and spreading. In a subgroup of patients
endometriosis is a preneoplastic condition. The persisting tissue healing
action of macrophages that keep interfering with the physiological apoptosis
while prompting proliferation of epithelial cells might set the scenario in
which genetic alterations accumulate.
results of progesterone withdrawal within endometriotic lesions
could cyclically activate inﬁltrating macrophages, thus sustaining
the inﬂammation associated to the disease.
Relatively little is known on the ability of peritoneal
macrophages to dispose of endometrial remnants, even if an
apparent impairment in the ability to phagocytose particulate sub-
strate has been reported (Chuang et al., 2009). The defect has been
associated with a defect in the expression and the function of the
class B scavenger receptor CD36, a well recognized player in the
recognition and clearance of apoptotic cells, in endometriosis:
such defect could be possibly related to the action of PG (Chuang
et al., 2010). However, it is difﬁcult to verify whether such defect
is upstream or downstream the persistent inﬂammation of the
peritoneal cavity associated to the disease.
Ectopic endometrium breakdown causes hemorrhage, with
extravasation and persistence of aging red blood cells within the
lesions; moreover erythrocytes accumulate into the pelvis because
of retrograde menstruation (Defrere et al., 2008, 2012; Lousse
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et al., 2009, 2012; Capobianco et al., 2010). The transfer of human
menstrual efﬂuent in immunodeﬁcient mice results in the gen-
eration of iron deposits, which are similar to those observed in
patients (Defrere et al., 2006), demonstrating that the speciﬁc fea-
tures of the peritonealmicroenvironment do not allow an effective
processing of red blood cells, in contrast to other professional
hemocatheretic tissues, such as the spleen.
The clearance of red blood cells and of apoptotic remnants
has similar molecular constrains and often relies on common
phagocytic tags/receptors pairs, which are in general expressed
by professional phagocytes, such as macrophages (Ravichandran,
2011). The peritoneal ﬂuid of endometriotic women indeed con-
tains iron-loaded macrophages and higher ﬂuid concentrations
of the metal, which are possibly associated with the severity
of the disease manifestations (Lousse et al., 2012). The iron in
the ﬂuid possibly derives from the lysis of red blood cells that
that are not effectively cleared by macrophages, and as a con-
sequence release hemoglobin. This moiety may as well bind to
haptoglobin and be internalized by macrophages via the CD163
hemoglobin/haptoglobin scavenger receptor. In endometriosis
patients this pathway is either originally defective or peritoneal
macrophages become insufﬁcient/unable to deal with the amounts
of hemoglobin present in the liquid. The concentration of free
iron within endometriotic cysts has also been investigated and
found to be high. Metal accumulation was reﬂected by a higher
oxidative stress, which in turn favors epigenetic modiﬁcations,
prompting the evolution of ectopic tissue in bona ﬁde neoplastic
lesions (Yamaguchi et al., 2008, 2010).
Macrophages are also able to directly recognize senescent ery-
throcytes, internalize and digest them, an event which in the bone
marrow is necessary for the active recycling of heme-iron for effec-
tive erythropoiesis (Li andGinzburg,2010; Ganz,2012). Peritoneal
macrophages are known to accumulate iron (Lousse et al., 2009).
So far relatively little information is available on the characteris-
tics of the macrophages disposal of red blood cells and heme-iron
within endometriotic lesions, in particular when progesterone
withdrawal jeopardizes the integrity of the vessel walls.
All together iron homeostasis is disrupted in the peritoneal
cavity of patients with endometriosis: the accumulation of unscav-
enged iron associates with the increased generation of ROS and
with a persistently activated pathway of the NF-kB: alterations
of this pathway have been reported in eutopic endometrium of
patients with endometriosis, suggesting a possible causative role
in the natural history of the disease (Ponce et al., 2009). Interest-
ingly polymorphism of the NFKB1 promoter have been described
that are signiﬁcantly associated with an increased risk to develop
endometriosis (Zhou et al., 2010).
The peritoneal environment, whose characteristics are mod-
ulated by a vast and complex array of regulatory peptides and
growth factors (Petraglia et al., 2008; Florio et al., 2009), could
further promote and amplify the function of alternatively acti-
vated macrophages. Immune and non-immune cells for example
produce urocortin neuropeptides, especially under inﬂammatory
stimuli and hypoxic conditions (Buhler et al., 2009; Imperatore
et al., 2010). Neuropeptides have been involved in the resolu-
tion/termination of the innate response, possibly via regulation
of the production of inﬂammatory cytokines and of endothelial
permeability (Di Comite et al., 2007, 2009). It has been recently
shown the various members of the urocortin families are dif-
ferentially expressed in ectopic and eutopic endometrium: their
expression is ﬁnely regulated throughout the menstrual cycle
in the eutopic tissue, while virtually no menstrual-cycle-related
changes were found in endometriotic lesions (Novembri et al.,
2011). Intriguingly, urocortin down-regulates secretion by acti-
vated macrophages of the best-characterized DAMP signal, the
high-mobility group box 1 (HMGB1) nuclear protein, suggest-
ing that macrophages are major targets in its inhibitory activity
(Chorny and Delgado, 2008). HMGB1 constitutively promotes
angiogenesis and is used by inﬂammatory macrophages to attract
vessel-associated stem cells and to favor tissue remodeling (Cam-
pana et al., 2009; Lolmede et al., 2009). HMGB1 physically asso-
ciates with CXCL12 and speciﬁcally modulates the CXCL12/CXC
chemokine receptor 4 (CXCR4) pathway (Zhao et al., 2007; Cam-
pana et al., 2009; Schiraldi et al., 2012), i.e., a crucial chemotactic
pathway involved in the recruitment of phagocytes and of stem
cells at sites of hypoxia. Other endogenous negative signals regu-
lating HMGB1 action have been described (Bianchi andManfredi,
2009), but their involvement in the pathogenesis of endometriosis
have not so far been extensively studied.
THE DEVELOPMENT OF ENDOMETRIOSIS DEPENDS ON MACROPHAGES
Animal models represent a useful tool to study in vivo early steps
of the natural history of endometriosis, which would be impossi-
ble to tackle in patients. Small animals and rodents in particular
have several advantages and have prompted in the last decades a
substantial in our insight of the pathogenesis of the disease: they
are relatively inexpensive, inbred animals are available, including
genetically modiﬁed models, in which the endometrial tissue can
be transferred and relevant biological events evaluated in refer-
ence to the characteristics of the developing lesions (Becker et al.,
2006; Tirado-Gonzalez et al., 2012). Lesions in murine models are
surgically induced, for example by micro-laparatomic techniques
(Nisolle et al., 2000) or induced by injection of endometrial tissue
of various origin within the peritoneal cavity (Somigliana et al.,
1999, 2001; Fainaru et al., 2008). The latter approach, as originally
described, rely on the transfer of fragments of endometrial tissue
harvested from syngeneic donor mice and recapitulates important
aspects of the disease, comprising hormone-dependence, ability
to escape immune surveillance, and characteristics of the neo-
vascularization of ectopic endometrium (Somigliana et al., 1999).
Endometriotic lesions are known to originate only in somemouse
strains, a feature that resembles the heterogeneous sensitivity to
the diseases of the human population.
It must however be underlined that these models have sub-
stantial disadvantages (Tirado-Gonzalez et al., 2010): in particular,
rodents do not menstruate and thus do not per se develop
endometriosis. As a consequence biological events are missing
that are substantially inﬂuence the natural history of the diseases,
such as the cyclic disruption of the ectopic endometrium as a
consequence of variation of the systemic concentration of sexual
hormones (discussed above) and the accumulation of iron in the
lesions and the peritoneal cavity.
We have used an experimental mouse model (Figure 2) to
verify whether macrophages are actually required and inﬂuence
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the establishment of endometriotic lesions. We have depleted
macrophages by the intraperitoneal injection of clodronate encap-
sulated into liposomes: this system results in the selective tar-
geting of clodronate to macrophages, that are killed without
undue toxicity on cells belonging to other lineages (Van Rooi-
jen and Sanders, 1994; Bacci et al., 2009; Cottone et al., 2011).
We have observed that in the absence of macrophages, syn-
geneic endometrium retains the ability to adhere to the peritoneal
layer and to inﬁltrate the serosal membrane. However, ectopic
lesions fail to grow in these conditions. The pharmacological
depletion of macrophages at later times, when endometriotic
lesions have already established and organized, “congeal” them:
vessels donot extend to the lesions core,which stop growing anddo
not develop a well-organized glandular and stromal architecture
(Bacci et al., 2009).
The data suggest that the recruitment of macrophages into the
lesions is not only an early event in the lesion development, but
a necessary step for the successful establishment of endometri-
otic lesions. Interestingly, a similar differential sensitivity of the
early phases of the diseases, which are not affected, versus the later
growth neovascularization and spreading of lesions characterizes
immunodeﬁcient mice that do not express the Tgfb1 transplanted
with human eutopic endometrial tissue (Hull et al., 2012). Mem-
bers of the TGF-β family have been implicated both in the
initiation of menstruation and in repair of eutopic endometrium
(Omwandho et al., 2010). Moreover, TGF-β is critically expressed
in endometriotic lesions (Omwandho et al., 2010).
Transforming growth factor β locally increases the expression
of the PAR2 gene with possible downstream increased secretion of
IL-6 from endometriotic stromal cells thus suggesting an upstream
role of the cytokine in coordinating the cascade of inﬂammatory
signals of the disease (Saito et al., 2011). TGF-β is a key factor
producedbymacrophages challengedwith apoptotic cell remnants
(Xiao et al., 2008), which as such could represent a relevant source
of the cytokine.
Macrophage dependence is not limited to mice, since ini-
tiation and growth of endometriotic lesions are both jeopar-
dized in a rat model of the disease after depletion of peri-
toneal macrophages by local injection of liposomal alendronate
(Haber et al., 2009). Of interest, in this model the degree of
lesion inﬁltration by macrophages is directly correlated with
the peritoneal concentrations of TNF-α, while those of the CC
chemokine ligand 2 (CCL2)/monocyte chemoattractant protein 1
(MCP-1) chemokine are negatively correlated with the degree of
macrophage inﬁltration (Haber et al., 2009). As discussed above,
macrophages deliver trophic and anti-apoptotic signals. These
effects in the early phase after endometrium injection are likely
to be more relevant (Lin et al., 2006), before novel vessels have
established (Eggermont et al., 2005; Grummer, 2006; Becker et al.,
2008), which promote the survival of ectopic cells in an hypoxic
environment (Lin et al., 2006).
REPARATIVE AND PRO-ANGIOGENETIC MACROPHAGES IN
ENDOMETRIOSIS
Macrophages from patients with endometriosis and mice with
implanted endometriotic lesions (but not peritoneal macrophages
from non-endometriotic patients or from control mice) express
typical markers of alternative activation, in particular high lev-
els of scavenger receptors, CD163 and CD206 (Bacci et al.,
2009). CD206 belongs to the C-type lectin superfamily is a
well-characterized PRR and contributes to remove or inacti-
vate inﬂammatory signals (Allavena et al., 2004). CD163 medi-
ates endocytosis of haptoglobin-hemoglobin complexes, with
degradation of heme-iron components that can be recycled for
erythropoiesis (Kristiansen et al., 2001; Borda et al., 2008), a fea-
ture that may be particularly important in a disease in which
disturbance of macrophage iron homeostasis appear particu-
larly important (see above). Macrophage polarization results in
differential iron management in both human and mice, with clas-
sically activated M1 macrophages that are characterized by iron
sequestration, which operates as a bacteriostatic mechanism
(Cairo et al., 2011).
In contrast alternatively activated M2 macrophages are
endowed with the ability to effectively internalize and recycle the
metal, with is reﬂected by a larger intracellular labile iron pool
(Corna et al., 2010; Recalcati et al., 2010). The ability to uptake
and recycle the metal to bystander cells could be relevant for
the repair of tissues in which large amount of heme-iron are
expressed, such as the skeletalmuscle or themyocardium (Brunelli
and Rovere-Querini, 2008; Corna et al., 2010) and may conversely
be involved in sustaining the proliferation of neoplastic cells and
the growth of neoplastic lesions (Recalcati et al., 2010; Cairo et al.,
2011). It is tempting to speculate that the skewing of endometri-
otic macrophages toward alternative activation results in a more
effective transfer of the metal to epithelial cells, with the effect to
support the growth and the spreading of the lesions. This model
would nicely ﬁt with the increased extracellular concentration of
iron in the peritoneal ﬂuid of patients with endometriosis, as
well as with the relative overload of macrophages with the metal
(Defrere et al., 2012).
Macrophages are alternatively activated in the inﬂammatory
peritoneal ﬂuid or in the endometriotic lesions, both in patients
and experimental animals (Bacci et al., 2009). This suggests that
this program is important for the natural history of the disease.
To experimentally address this possibility, we have set up a model
of cell transfer with various polarized macrophage populations in
mice in which the endogenous macrophage population had been
previously depleted (see above). In this system, alternatively acti-
vated macrophages strongly enhance the growth of endometriotic
lesions. In contrast mice injected with conventionally activated
inﬂammatory macrophages develop minute lesions, that do not
grow and are characterized by a severely disrupted glandular and
stromal architecture (Bacci et al., 2009).
Given the critical role of lesions neovascularization in their
outcome, we have focused on the possible role of TEMs, the
best-characterized population of macrophages involved in angio-
genesis: this subset has mainly been characterized in tumor
models (De Palma andNaldini, 2011) but it has convincingly been
suggested to play a role even in non-neoplastic conditions, in par-
ticular in the physiological development of embryos (Pucci et al.,
2009). We have observed that human TEMs inﬁltrate areas sur-
rounding endometriotic novel vessels (Capobianco et al., 2011). To
obtain a mouse model in which TEMs, and not Tie2-expressing
endothelial cells, are targeted we have transplanted in wild-type
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recipients bone marrow progenitor cells expressing a suicide gene
under the Tie2 promoter/enhancer. In this system, TEMs effec-
tively inﬁltrated endometriotic lesions, whose growth abruptly
abates after TEM depletion. Of interest, in the absence of TEMs
endothelial cells caspase 3 is activated. This results in disrup-
tion of vessel integrity and of glandular architecture, suggesting
a paracrine action of signals delivered by TEMs on the survival of
endothelial cells within the neovessel wall.
ENDOMETRIOSIS AS A PRENEOPLASTIC CONDITION: A ROLE OF
MACROPHAGES?
Endometriotic tissue comprises non-transformed cells only. How-
ever, it shares several features with neoplasms (uncontrolled
growth, invasion of adjacent tissues, defective apoptosis, sus-
tained local inﬂammatory responses). Conversely, endometrio-
sis increases the risk of ovarian cancer, in particular invasive
low-grade serous, clear-cell, and endometrioid subtypes of the
neoplasm (Yamaguchi et al., 2008, 2010; Pearce et al., 2012). The
molecular bases of the association are not completely deﬁned.
As discussed above, macrophages are physiologically recruited in
injured tissues, where they activate the neo-angiogenic switch,
sustain resistance to apoptotic stimuli and stimulate the prolifer-
ation and invasion of precursor cells, in order to prompt tissue
regeneration. Macrophages recruited in the endometriotic lesions
activate a similar program: they interfere with physiological apop-
tosis while prompt proliferation, thus setting the scenario in which
genetic alterations accumulate. This action may contribute to the
evolution of lesions toward atypical endometriosis and metapla-
sia, which in turn fosters the development of borderline and ﬁnally
fully malignant ovarian cancer (Wei et al., 2011). Further studies
are required to experimentally address this possibility.
CONCLUSION
Endometriosis represents an immunological unique scenario,
since it derives from the auto-transplantation of endometrial cells
at distant sites. Recent studies have identiﬁed lesionalmacrophages
as responsible for the outcome of the auto-transplantation, since
their unrestrained activation toward a reparative phenotype allows
the survival, the neovascularization, and the growth of the lesions.
This event possibly depends on the transfer at distant sites of
inﬂammatory regenerative mechanisms that are physiologically
activated to repair the eutopic endometrium during themenstrual
cycle. Clarifying the molecular mechanisms of the misperception
of macrophages is a critical area for the development of novelmed-
ical treatments of endometriosis, an urgent and unmet medical
need.
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